Members of ethnic communities around the globe suffer from rare diseases unique to their demographic group. Their genetic makeup makes them more susceptible to hereditary
Diversity in Clinical Trials: Going Beyond Why to How Diversity is a hot-button issue within the global medical community. The industry continues to seek effective
Developing a patient-centric and compliant study is a top priority for any team. Understanding the importance of Institutional Review Boards (IRB) and Ethics Committees (EC) and their role is critical to a successful clinical trial.
Do your clinical trial patients need stipends, reimbursements, or a combination of payment types? Not sure? Many study teams are unsure about the different types
Recruiting and enrolling patients is often an uphill battle for sponsors of rare and ultra-rare disease trials. The unique patient populations are located across the
Focus on the Patient and Your Trial Outcome, Not on Logistics
Learn more about improving your clinical trials.